Heart Pumps Market: By Type (Left ventricular assist device (LVAD), Right ventricular assist device (RVAD), Others), By Flow Rate (Continuous Flow, Pulsatile) By End User(Hospitals, Ambulatory Surgical Centres, Others), By Geography  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Global heart pumps market expected to grow at significant rate owing to increase in cases heart failure around the world. heart pumps are the one of the promising treatment option for the heart failure patients. Market has many of the players and comprising of huge competition among them. Companies are collaborating to other technological companies in development of the new and innovative products for company market growth. Furthermore, larger companies are focusing on the product launches and acquisition of the other companies in the market to strengthen their position. Heart failure is also referred as congestive heart failure. It is the condition at which heart is unable to pump the sufficient blood to the body parts. Certain conditions such as narrowed arteries (coronary artery disease or high blood pressure results in weakening the heart and stiffening the arteries lead to difficulties in pumping of blood. Heart pumps are used to support or replace the blood flow and heart function in the people with weak cardiac function and patients with heart failure. Heart pumps are implantable devices and can be used temporarily to help the heart rate and blood flow or can use permanently. In some patients usage of heart pumps may allow the heart to recover and function normally. For instance, in April, 2018, Abiomed, Inc. has received U.S. FDA Pre-Market Approval (PMA) for its Impella CP heart pump with SmartAssist.

Heart Pumps Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Market Dynamics

Increase in prevalence of cardiovascular diseases across regions is one the major factors expected to drive the revenue growth of heart pumps market globally. Lifestyle related factors are expected to add to growing disease incidence of CVDs. In addition growing number of obese patients are expected to bolster the heart pumps market. ast track approvals of cardiac devices in developed countries will propel sales revenues for the companies advanced technologies also propel the growth of heart pumps market. However, factors such as availability of alternative treatment options expected to hinder the market growth. Furthermore, high cost of devices and stringent regulatory procedures may act as restraints for the growth of global heart pumps market over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021) and forecast (2022-2028).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market The report tracks recent innovations, key developments and startup’s details that are actively working in the market .
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario.
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market.

Heart Pumps Market Segmentation

By Type
  • Left ventricular assist device (LVAD)
  • Right ventricular assist device (RVAD)
  • Others
By flow rate
  • Continuous Flow
  • Pulsatile
by End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Geography
North America
  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America
Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Calon Cardio-Technology Ltd. (U.K.)
  • SynCardia Systems, Inc. (U.S.)
  • Medtronic (U.S.)
  • Berlin Heart GmbH (Germany)
  • CHF Solutions, Inc. (U.S.)
  • Teleflex Incorporated (U.S.)
  • MAQUET GmbH & Co. (Germany)
  • Abiomed (U.S.)
  • Abbot Laboratories (U.S.)